跳至主要内容
临床试验/IRCT20190703044084N2
IRCT20190703044084N2已完成3 期

The effect of ondansetron in the treatment of patients with diarrhea dominant irritable bowel syndrome (IBS)

Zanjan University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Patients with irritable bowel syndrome with diarrhea predominance based on Rome III criteria
  • Age:Between 18-50 years

排除标准

  • Dissatisfaction to be included in the study
  • Any sign and symptom of inflammatory bowel disease
  • Psychiatric drug use
  • Drugs Interaction with ondansetron including: p450 enzyme system inducers (carbamazepine, phenobarbital, phenytoin, dexamethasone, rifampicin) p450 enzyme system inhibitors (clarithromycin erythromycin ketoconazole) 3
  • History of any bowel surgery except appendectomy and cholecystectomy

研究者

相似试验